A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Murdoch Childrens Research Institute
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Chongqing Peg-Bio Biopharm Co., Ltd.
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Boston Children's Hospital
Center for International Blood and Marrow Transplant Research
Centre Henri Becquerel
Fayoum University
Thomas Jefferson University
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
University Hospital, Grenoble
Duke University
Beijing Suncadia Pharmaceuticals Co., Ltd
Fadoi Foundation, Italy
Fred Hutchinson Cancer Center
Thomas Jefferson University
Jiangsu HengRui Medicine Co., Ltd.
Thomas Jefferson University
Rigshospitalet, Denmark
University of Aberdeen
Fred Hutchinson Cancer Center
University of Utah
LEO Pharma
Centre Hospitalier Annecy Genevois
AstraZeneca
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University Hospital, Angers
Radboud University Medical Center
Radboud University Medical Center
Advice Pharma Group srl
Centre Leon Berard
Assistance Publique - Hôpitaux de Paris
Ottawa Hospital Research Institute
Duke University
National Cancer Institute (NCI)
Radboud University Medical Center
Medical College of Wisconsin
National Cancer Institute (NCI)
King's College Hospital NHS Trust
AstraZeneca
Memorial Sloan Kettering Cancer Center
Swiss Federal Institute of Technology
AstraZeneca
Ohio State University Comprehensive Cancer Center